Prevalence of DLL3, CTLA-4 and MSTN Expression in Patients with Small Cell Lung Cancer
Orgilmaa Regzedmaa,1,* Ying Li,2,* Yongwen Li,2,* Hongbing Zhang,1 Jin Wang,2 Hao Gong,1 Yin Yuan,1 Weiting Li,1 Hongyu Liu,2 Jun Chen1,2 1Department of Lung Cancer Surgery, Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Medical University General Hospital, Tian...
Main Authors: | Regzedmaa O, Li Y, Zhang H, Wang J, Gong H, Yuan Y, Li W, Liu H, Chen J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-11-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/prevalence-of-dll3-ctla-4-and-mstn-expression-in-patients-with-small-c-peer-reviewed-article-OTT |
Similar Items
-
Correlation of DLL3 Expression with Platinum-based Chemotherapy Efficacy and Prognosis of Advanced Small Cell Lung Cancer
by: HAN Shuhua, et al.
Published: (2020-11-01) -
DETECTION OF MSTN POLYMORPHISM IN RABBIT
by: ALICA RAFAYOVÁ, et al.
Published: (2009-10-01) -
MSTN gene polymorphism in livestock animals
by: Monika Stefaniuk, et al.
Published: (2014-05-01) -
Polymorphism of Myostatin Gene (MSTN) Coding Region in Batur Sheep
by: Hassan Ishag Hassan Haren, et al.
Published: (2019-02-01) -
Up-regulation of DLL1 May Promote the Chemotherapeutic Sensitivity
in Small Cell Lung Cancer
by: Huanxin LIU, et al.
Published: (2013-06-01)